Rondina, Merlyn D.

HRN: 00-22-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/28/2024
01/04/2024
IV
600mg
Q6H
INFECTED WOUND
Waiting Final Action 
01/28/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/28/2024
02/04/2024
IV
2.25G
Q6H
INFECTED WOUND
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: